Filing Details
- Accession Number:
- 0001209191-16-145680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-12 12:24:09
- Reporting Period:
- 2016-10-11
- Filing Date:
- 2016-10-12
- Accepted Time:
- 2016-10-12 12:24:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594935 | Russell Lawrence Smith | 10390 Pacific Center Court San Diego CA 92121 | Vp, Vaccine Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Disposition | 2016-10-11 | 54 | $3.05 | 23,125 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of 54 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on June 6, 2016.
- Share amounts have been adjusted to give effect to a 1-for-10 reverse stock split on May 26, 2016.
- This balance includes 5,229 unvested shares subject to restricted stock units.
Billionaire Hedge Funds
